360 Results (Page 4 of 15)
India Markets Research Reports
India Healthcare Financial Analytics Market Analysis
India's Healthcare Financial Analytics market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.8% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by type, component, and deployment. India’s Healthcare Financial Analytics market will grow as the adoption of technology in the healthcare industry is increasing in India, which is driving demand for healthcare financial analytics solutions. The key market players are CitiusTech, Innovaccer, Tricog, Medikabazaar, Indegene, Napier Healthcare Solutions, Tech Mahindra, Vitra.ai, CloudMD, Practo, and others.
India Healthcare Diagnostics Market Analysis
This report presents a strategic analysis of the India Healthcare Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the India Healthcare Diagnostics Market, offering unmatched value, accuracy, and expert insights.
India ENT Devices Market Analysis
India's ENT Devices Market is projected to grow from $420 Mn in 2022 to $820 Mn by 2030, registering a CAGR of 9% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the India ENT devices market include Phoenix Medical Systems, Surgitech Innovations, and Zephyr Surgicals.
India Digital Therapeutics Market Analysis
This report presents a strategic analysis of the India Digital Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the India Digital Therapeutics Market, offering unmatched value, accuracy, and expert insights.
India Diabetes Devices Market Analysis
India's Diabetes Devices Market is expected to witness growth from $413 Mn in 2022 to $899 Mn in 2030 with a CAGR of 10.20% for the forecasted year 2022-30. In 2020, over 77 million adults in India have diabetes, making it one of the countries with the highest prevalence of the illness. The nation's demand for diabetes devices is anticipated to be driven by the high incidence of diabetes. The market is segmented by type and by the end user. Some key players in this market include Poly Medicure, Biosurge Healthcare, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care, and Dexcom.
India Cardiac Surgery Instruments Market Analysis
India's Cardiac Surgery Instruments Market is expected to witness growth from $38 Mn in 2022 to $78 Mn in 2030 with a CAGR of 9.60% for the forecasted year 2022-30. India has a significant incidence and prevalence of Cardiovascular Diseases (CVD), including coronary artery disease, heart failure, and hypertension. The demand for cardiac surgery equipment in the Indian healthcare industry is anticipated to rise as CVD prevalence in that country continues to rise. The market is segmented by type, application, and end user. Some key players in this market include Becton Dickinson, GPC Medical, Sahajanand Medical Technologies, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
India Acne Therapeutics Market Analysis
India's acne therapeutics market is expected to witness growth from $182 Mn in 2022 to $383 Mn in 2030 with a CAGR of 9.7% for the forecasted year 2022-30. due to the increasing demand for combination therapies and associated results for acne treatment. The market is segmented by treatment, route of administration, age group, and by distribution channel. Cipla Pharmaceuticals, Glenmark Pharmaceuticals, and Teva Pharmaceuticals are some of the leading companies in India's acne therapeutics market.
India Connected Healthcare Market Analysis
India-connected healthcare market is projected to grow from $1.21 Bn in 2022 to $10.73 Bn by 2030, registering a CAGR of 31.4% during the forecast period of 2022-30. The main factors driving the growth would be increasing healthcare needs, growing smartphone penetration, increasing healthcare spending, and government initiatives. The market is segmented by type, function, and application. Some of the major players include Practo, HeyDoc, Omron Healthcare, TATA 1mg, Philips Healthcare, GE Healthcare, Cisco Systems, and IBM.
India Over The Counter (OTC) Pharmaceuticals Market Analysis
India's over-the-counter (OTC) pharmaceuticals market size was valued at $2500.6 Mn in 2022 and is estimated to expand at a CAGR of 8.54% from 2022 to 2030 and will reach $4816.8 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.
India Anemia Drugs Market Analysis
India's Anemia drugs market was valued at $291 Mn in 2022 and is estimated to expand at a CAGR of 11.9% from 2022-30 and will reach $714 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Sun Pharmaceutical Industries, Cipla, Dr. Reddy's Laboratories, Torrent Pharmaceuticals, and Alkem Laboratories among others.
India Alexipharmic Drugs Market Analysis
India's Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 7.70% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The India Alexipharmic Drugs market will grow because the Indian government has also implemented policies to improve access to healthcare in rural areas, including the provision of antidotes in village-level healthcare centers. The key market players are Bharat Serums and Vaccines Ltd (IND), Serum Institute of India, Sun Pharmaceutical Industries Ltd (IND), and others.
India Diagnostic Imaging Services Market
The India Diagnostic Imaging Services market size was valued at $9.54 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.9 % from 2022 to 2030 and will reach $17.54 Bn in 2030. The market is segmented by product, application, and end user. The India Diagnostic Imaging Services market will grow as the development of new 3D printing materials and techniques has led to the production of more complex and customizable medical devices. The key market players are Wipro GE Healthcare Pvt. Ltd. (Bangalore), Siemens Healthcare Private Limited (Gurgaon), Philips India Limited (Gurgaon), Toshiba Medical Systems India Pvt. Ltd. (Gurgaon), Hitachi Healthcare Manufacturing, Ltd. (Ahmedabad), Mindray Medical India Pvt. Ltd. (Mumbai), and others.
India Patient Engagement Solutions Market Analysis
India's engagement solutions market is projected to grow from $309.34 Mn in 2022 to $959.54 Mn by 2030, registering a CAGR of 15.2% during the forecast period of 2022-30. The main factors driving the growth would be the growing healthcare market, the rising burden of chronic diseases, government initiatives, and the rapid digitalization of healthcare. The market is segmented by component, delivery mode, application, therapeutic area, functionality, and by end-user. Some of the major players include Practo, BestDoc, Clinion, Allscripts, and Cerner.
India Neurology Clinical Trials Market Analysis
India's Neurology Clinical Trials market is projected to grow from $95.1 Mn in 2022 to $182.7 Mn by 2030, registering a CAGR of 8.5% during the forecast period of 2022-30. The market will be driven by the high prevalence of neurological disorders and the low cost of conducting clinical trials in India. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis, Sun Pharmaceutical Industries & Cadila Healthcare.
India Liver Disease Drugs Market Analysis
This report presents a strategic analysis of the India Liver Disease Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the India Liver Disease Drugs Market, offering unmatched value, accuracy, and expert insights.
India Multiple Myeloma Therapeutics Market Analysis
India's multiple myeloma therapeutics market was valued at $152 Mn in 2022 and is estimated to expand at a CAGR of 7.5% from 2022 to 2030 and will reach $271 Mn in 2030. One of the main reasons propelling the growth of this market is the increase in prevalence, Increasing awareness, and screening programs. The Market is segmented by type, drug, and distribution channel. Some key players in this market are Natco Pharma, Cipla, Hetero Drugs, Biocon, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, Lupin, Cadila Healthcare, and others.
India Electronic Health Records Market Analysis
India's electronic health record market size was valued at $514 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7% from 2022 to 2030 and will reach $884 Mn in 2030. This growth can be attributed to hospitals seeing benefits from EMR implementation and integration with their core operations. The market is segmented by product type, application type, and end user. Some of the major players DocEngage Informatics, Gem3s Technologies, NovoCura Tech Health Services, Practo Technologies, Cerner Healthcare, and others.
India eHealth Market Analysis
This report presents a strategic analysis of the India eHealth Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the India eHealth Market, offering unmatched value, accuracy and expert insights.
India Palliative Care Market Analysis
India's Palliative care market is projected to grow from $237.87 Mn in 2022 to $548.19 Mn by 2030, registering a CAGR of 11% during the forecast period of 2022-30. The main factors driving the growth would be the ageing population, the growing healthcare industry, and government support. The market is segmented by service type and by the end user. Some of the major players include Manipal Hospital, Narayana Health, Max Healthcare, Kokilaben Dhirubhai Ambani Hospital, and Arthemis Health Sciences.
India Anti-Aging Drugs Market Analysis
This report presents a strategic analysis of the India Anti-Aging Drugs Market Analysis and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the India Anti-Aging Drugs Market Analysis, offering unmatched value, accuracy, and expert insights.
India AADC Deficiency Market Analysis
India AADC Deficiency Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. The growing awareness of rare diseases like AADC deficiency among the general public and medical community is one of the major factors influencing market expansion. More cases are being diagnosed as the illness gains recognition, which results in early treatment and better patient outcomes. As medical professionals become more familiarized with the illness and its symptoms, it is expected that this tendency will continue.Major global players in AADC Deficiency Market are Lysogene, Retrophin, Ultragenyx Pharmaceutical, PTC Therapeutics, Azevan Pharmaceuticals, Neurocrine Biosciences, Adrenomed AG, Renova Therapeutics, Titan Pharmaceuticals, Voyager Therapeutics.
India Acute Myeloid Leukemia Market Analysis
India Acute Myeloid Leukemia Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. The ageing population, higher drug approval rates, the designation of acute myeloid leukaemia as an orphan disease, and rising healthcare costs are anticipated to drive the market. One of the factors accelerating the market's growth is the technological advancement made possible by the capacity to recognise damaged cells. Major global players in Acute Myeloid Leukemia Market are Ambit Biosciences Corporation, Genzyme Corporation, Celgene Corporation, Clavis Pharma ASA, Sunesis Pharmaceuticals, Cephalon, Bristol-Myers Squibb, Novartis International AG, GlaxoSmithKline.
India Adrenoleukodystrophy (ALD) Drugs Market Analysis
India Adrenoleukodystrophy (ALD) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Drivers of acromegaly market are increasing cases of the disorder which in turn increased awareness and government focus motivated financial support to R&D. Poxel SA, Bluebird Bio Inc.,Viking Technologies, Minoryx Therapeutics sl., Apteeus SAS, Ashvattha Therapeutics LLC, NeuroVia Company, Autobahn Therapeutics Inc., Aldagen Inc., Celularity Inc., Imstem Biotechnology Inc., MedDay SA, and Orpheris Inc. are major competitors in the Global Adrenoleukodystrophy (ALD) drugs Market.
India Ankylosing Spondylitis Drugs Market Analysis
India Ankylosing Spondylitis Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Ankylosing spondylitis is a kind of arthritis that affects connective tissues. The sacroiliac joints, which connect the spine to the pelvis, become inflamed, but in extreme situations, the spine's bones might fuse together and become very inflexible. A rough estimate of 1.1 Mn Americans, or one out of every 200 adults, are impacted. Abbvie, Amgen, Eli Lilly, Janssen, Merck, Pfizer, Novartis, UCB, and many other leading companies are active in the ankylosing spondylitis global market. To increase their market share, these businesses engage in strategic alliances and acquisitions in addition to concentrating on research and development to bring novel therapies to market.
India CDKL5 deficiency disorder (CDD) market Analysis
India CDKL5 deficiency disorder Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for CDKL5 deficiency disorder is expanding as a result of increase in global prevalence of CDKL5 deficiency disorder and increase in awareness about neurological diseases. In addition, high expenditure on healthcare and genetic testing, growing demand for targeted therapies, increase in R&D spending for the discovery of novel pharmaceuticals are other reasons . This demand is fueling the development of better pharmaceuticals and other treatment methods for the accurate treatment of CDKL5 deficiency disorder. Some of the key players in the global CDKL5 deficiency disorder market include Marinus pharmaceuticals, REGENXBIO, Zogenix, PTC therapeutics and Ovid therapeutics/ Takeda